ACTM-838, a novel systemically delivered bacterial immunotherapy that enriches in solid tumors and delivers IL-15/IL-15Rα and STING payloads to engage innate and adaptive immunity in the TME and enable a durable anti-tumor immune response
Oncotarget · 2025
DOI: 10.18632/oncotarget.28769 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncotarget, 2025. Verfasst von Kyle R Cron und 17 weiteren Autor:innen. Beteiligte Einrichtung: Actym Therapeutics, Berkeley, CA 94710, USA. Hauptthemen laut MEDLINE: Tumor Microenvironment, Interleukin-15, Immunotherapy, Membrane Proteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Actym Therapeutics, Berkeley, CA 94710, USA.
Zitieren
APA
Cron, K. R., Fang, P., Pham, O., Janes, J., Brandenburg, J., Lu, W., Zhu, J., Peterson, B., Tribble, S., Kehoe, H., Makarova, A., Iannello, A., Chan, J., Skoble, J., He, H., Rae, C., Thanos, C. D., & Udyavar, A. R. (2025). ACTM-838, a novel systemically delivered bacterial immunotherapy that enriches in solid tumors and delivers IL-15/IL-15Rα and STING payloads to engage innate and adaptive immunity in the TME and enable a durable anti-tumor immune response. Oncotarget. https://doi.org/10.18632/oncotarget.28769
Vancouver
Cron KR, Fang P, Pham O, Janes J, Brandenburg J, Lu W, et al. ACTM-838, a novel systemically delivered bacterial immunotherapy that enriches in solid tumors and delivers IL-15/IL-15Rα and STING payloads to engage innate and adaptive immunity in the TME and enable a durable anti-tumor immune response. Oncotarget. 2025. doi:10.18632/oncotarget.28769
BibTeX
@article{Cron2025,
author = {Cron, Kyle R and Fang, Ping and Pham, Oanh and Janes, Julie and Brandenburg, John and Lu, William and Zhu, Jonathan and Peterson, Bret and Tribble, Sara and Kehoe, Haixing and Makarova, Anastasia and Iannello, Alex and Chan, Jean and Skoble, Justin and He, Hailey and Rae, Chris and Thanos, Christopher D and Udyavar, Akshata R},
title = {ACTM-838, a novel systemically delivered bacterial immunotherapy that enriches in solid tumors and delivers IL-15/IL-15Rα and STING payloads to engage innate and adaptive immunity in the TME and enable a durable anti-tumor immune response},
journal = {Oncotarget},
year = {2025},
doi = {10.18632/oncotarget.28769}
}
EUVIMED